Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1936-0541
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals ; volume:12 ; number:4 ; day:20 ; month:7 ; year:2018 ; pages:356-367 ; date:7.2018
Hepatology international ; 12, Heft 4 (20.7.2018), 356-367, 7.2018
- Urheber
-
Izumi, Namiki
- Beteiligte Personen und Organisationen
-
Takehara, Tetsuo
Chayama, Kazuaki
Yatsuhashi, Hiroshi
Takaguchi, Koichi
Ide, Tatsuya
Kurosaki, Masayuki
Ueno, Yoshiyuki
Toyoda, Hidenori
Kakizaki, Satoru
Tanaka, Yasuhito
Kawakami, Yoshiiku
Enomoto, Hirayuki
Ikeda, Fusao
Jiang, Deyuan
De-Oertel, Shampa
McNabb, Brian L.
Camus, Gregory
Stamm, Luisa M.
Brainard, Diana M.
McHutchison, John G.
Mochida, Satoshi
Mizokami, Masashi
SpringerLink (Online service)
- DOI
-
10.1007/s12072-018-9878-6
- URN
-
urn:nbn:de:101:1-2018100519295085954330
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Izumi, Namiki
- Takehara, Tetsuo
- Chayama, Kazuaki
- Yatsuhashi, Hiroshi
- Takaguchi, Koichi
- Ide, Tatsuya
- Kurosaki, Masayuki
- Ueno, Yoshiyuki
- Toyoda, Hidenori
- Kakizaki, Satoru
- Tanaka, Yasuhito
- Kawakami, Yoshiiku
- Enomoto, Hirayuki
- Ikeda, Fusao
- Jiang, Deyuan
- De-Oertel, Shampa
- McNabb, Brian L.
- Camus, Gregory
- Stamm, Luisa M.
- Brainard, Diana M.
- McHutchison, John G.
- Mochida, Satoshi
- Mizokami, Masashi
- SpringerLink (Online service)
Ähnliche Objekte (12)
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals